COMPASS Pathways plc

Stocks

CMPS

US20451W1018

Market Closed - Nasdaq Other stock markets 04:00:00 2026-07-08 pm EDT			Pre-market 07:14:17 am
13.96 ^USD	+7.51%		14.01	+0.32%

Jul. 08	Compass Pathways' COMP360 Data Supports FDA Approval Potential, RBC Says	MT
Jul. 07	Compass Pathways Says Second Phase 3 Trial Confirms Durable Benefit of Depression Treatment	MT

Transcript : COMPASS Pathways plc - Special Call

Published on 07/07/2026 at 10:38 am EDT - Modified on 07/08/2026 at 09:35 pm EDT

S&P Capital IQ

Add MarketScreener to your sources

Presentation Operator Message
Operator (Operator)

Good day, ladies and gentlemen, and welcome to the COMPASS Pathways Update Webinar. [Operator Instructions] As a reminder, this call is being recorded.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Add MarketScreener to your sources

Latest news about COMPASS Pathways plc

Jul. 08	Compass Pathways' COMP360 Data Supports FDA Approval Potential, RBC Says	MT
Jul. 07	Compass Pathways Says Second Phase 3 Trial Confirms Durable Benefit of Depression Treatment	MT
Jul. 07	COMPASS Pathways plc - Special Call
Jul. 07	Compass Pathways Reports Six-Month Data from Second Phase 3 Trial of Comp360 for Treatment-Resistant Depression	CI
Jun. 30	Healthcare Stocks Fall as Markets Rotate Back to Tech -- Healthcare Roundup	DJ
Jun. 26	European Equities Traded in the US as American Depositary Receipts Decline Friday	MT
Jun. 22	Definium's LSD-based depression pill delivers strong late-stage results, shares surge	RE
May. 28	Compass Pathways plc Announces Appointment of Kathleen Tregoning to Board of Directors	CI
May. 18	Trump's psychedelic drug order boosts investor interest with promise of faster reviews	RE
May. 14	RBC Raises Price Target on COMPASS Pathways to $22 From $21, Keeps Outperform, Speculative Risk	MT
May. 13	COMPASS Pathways plc Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
May. 13	COMPASS Pathways plc, Q1 2026 Earnings Call, May 13, 2026
May. 13	COMPASS Pathways Q1 Loss Widens	MT
May. 13	Earnings Flash (CMPS) COMPASS Pathways Posts Q1 Net Loss $0.30 a Share, vs. FactSet Est of $0.43 Loss	MT
May. 06	HEALTH ROUNDS-Researchers gain new insight into how psychedelics affect the brain	RE